CYMABAY THERAPEUTICS INC

CUSIP: 23257D103 Class: Common Stock

UBS Group AG's Holding History (CIK: 0001610520)

Note: Option positions (PUT/CALL) are excluded.

Q4 2023
Shares 138,241 Value ($000) $3,265 Avg Close Range
Q3 2023
Shares 132,500 Value ($000) $1,976 Avg Close Range
Q2 2023
Shares 53,867 Value ($000) $590 Avg Close Range
Q1 2023
Shares 69,800 Value ($000) $609 Avg Close Range
Q4 2022
Shares 285,736 Value ($000) $1,792 Avg Close Range
Q3 2022
Shares 495,238 Value ($000) $1,733 Avg Close Range
Q2 2022
Shares 455,265 Value ($000) $1,343 Avg Close Range
Q1 2022
Shares 31,459 Value ($000) $99 Avg Close Range
Q4 2021
Shares 57,142 Value ($000) $193 Avg Close Range
Q3 2021
Shares 31,797 Value ($000) $116 Avg Close Range
Q2 2021
Shares 36,481 Value ($000) $159 Avg Close Range
Q1 2021
Shares 119,370 Value ($000) $542 Avg Close Range
Q4 2020
Shares 128,944 Value ($000) $740 Avg Close Range
Q3 2020
Shares 36,070 Value ($000) $261 Avg Close Range
Q2 2020
Shares 378,867 Value ($000) $1,322 Avg Close Range
Q1 2020
Shares 371,902 Value ($000) $551 Avg Close Range
Q4 2019
Shares 84,509 Value ($000) $166 Avg Close Range
Q3 2019
Shares 158,386 Value ($000) $811 Avg Close Range
Q2 2019
Shares 74,800 Value ($000) $536 Avg Close Range
Q1 2019
Shares 80,976 Value ($000) $1,075 Avg Close Range
Q4 2018
Shares 35,117 Value ($000) $276 Avg Close Range
Q3 2018
Shares 55,952 Value ($000) $620 Avg Close Range
Q2 2018
Shares 141,581 Value ($000) $1,900 Avg Close Range
Q1 2018
Shares 32,232 Value ($000) $419 Avg Close Range
Q4 2017
Shares 8,670 Value ($000) $80 Avg Close Range
Q3 2017
Shares 3,000 Value ($000) $24 Avg Close Range
Q2 2017
Shares 4,738 Value ($000) $27 Avg Close Range
Q1 2017
Shares 3,759 Value ($000) $16 Avg Close Range
Q4 2016
Shares 7,069 Value ($000) $12 Avg Close Range
Q3 2016
Shares 3,000 Value ($000) $6 Avg Close Range
Q2 2016
Shares 6,128 Value ($000) $10 Avg Close Range
Q2 2015
Shares 6,771 Value ($000) $18 Avg Close Range
Q4 2014
Shares 329 Value ($000) $3 Avg Close Range